 |
|
LETTER TO THE EDITOR |
|
| Year : 2012 | Volume
: 7
| Issue : 3 | Page : 171 |
|
| Serum hepcidin and chronic obstructive pulmonary disease |
|
|
Beuy Joob1, Viroj Wiwanitkit2
1 Sanitation, Medical Academic Center, Bangkok, Thailand
2 Wiwanitkit House, Bangkhae, Bangkok, Thailand
| Date of Web Publication | 21-Jul-2012 |
Correspondence Address:
Beuy Joob
Sanitation, Medical Academic Center, Bangkok
Thailand
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1817-1737.98855
|
|
How to cite this article:
Joob B, Wiwanitkit V. Serum hepcidin and chronic obstructive pulmonary disease. Ann Thorac Med 2012;7:171 |
Sir,
The recent report on serum hepcidin and COPD is very interesting. [1] Duru et al. concluded that "serum hepcidin level may be a useful marker in COPD." [1] As Duru et al. proposed, a further confirmation is required. An important point is there is no complete assessment on hepatitis profile (such as hepatitis B, hepatitis C, etc.) needed. Also, some genetic disorders can also alter the hepcidin level that has to be ruled out. Thalassemia [2] as well as some other rare genetic mutations [3] should be ruled out. It is still very inconclusive to conclude for any usefulness of hepcidin as a new biomarker for COPD.
 References | |  |
| 1. | Duru S, Bilgin E, Ardiç S. Hepcidin: A useful marker in chronic obstructive pulmonary disease. Ann Thorac Med 2012;7:31-5. 
|
| 2. | Origa R, Galanello R. Pathophysiology of beta thalassaemia. Pediatr Endocrinol Rev 2011;8 (Suppl 2):263-70.
[PUBMED] |
| 3. | Melis MA, Cau M, Congiu R, Sole G, Barella S, Cao A, et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 2008;93:1473-9.
[PUBMED] |
|
|
| This article has been cited by | | 1 |
Authorsę reply |
|
| ArdiƧ, S. | | Annals of Thoracic Medicine. 2012; 7(3): 171-172 | | [Pubmed] | |
|
|
|
|
|
|
|
